Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Clara Lam"'
Autor:
Clara Lam, Brandon Diessner, Katherine Andrade, Sydnie Stackland, Leah Park, Sandhya Mehta, Feng Lin, Winghan Jackie Kwong
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 13, Iss 5 (2024)
Aim: The objectives were to investigate the differences in per patient per month (PPPM) healthcare resource utilization (HCRU) and costs among commercially insured and Medicare Advantage patients with human epidermal growth factor receptor 2 positi
Externí odkaz:
https://doaj.org/article/c3f4f6816e074ba3b209bf8f19663c85
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 395-404 (2023)
Abstract Background Trastuzumab in combination with chemotherapy is the standard first-line (1L) treatment for HER2+ metastatic gastric cancer (mGC) in the USA. Objective This study characterizes the real-world treatment patterns, healthcare resource
Externí odkaz:
https://doaj.org/article/0bdeeb8a0b404640af486a0dd0adf98b
Publikováno v:
Cancer Medicine, Vol 7, Iss 7, Pp 3434-3444 (2018)
Abstract Diabetes prevalence and racial health disparities in the diabetic population are increasing in the US. Population‐based cancer‐specific survival estimates for cancer patients with diabetes have not been assessed. The Surveillance, Epidem
Externí odkaz:
https://doaj.org/article/f312333489524b17893b317cfd4917bd
Autor:
Alexandre Hikiji Watanabe, Connor Willis, Melissa Pavilack-Kirker, Clara Lam, Leah Park, Sandhya Mehta, Jackie Kwong, Anindit Chhibber, Hillevi Bauer, Sabrina Ilham, Diana Brixner, David Stenehjem
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:CLO22-090
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::741cfa94724efc1e13e835a6035791c1
https://doi.org/10.6004/jnccn.2021.7276
https://doi.org/10.6004/jnccn.2021.7276
Autor:
Clara Lambert, Marine Gaillard, Paprapach Wongdontree, Caroline Bachmann, Antoine Hautcoeur, Karine Gloux, Thomas Guilbert, Celine Méhats, Bastien Prost, Audrey Solgadi, Sonia Abreu, Muriel Andrieu, Claire Poyart, Alexandra Gruss, Agnes Fouet
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract In Streptococcus pyogenes, the type II fatty acid (FA) synthesis pathway FASII is feedback-controlled by the FabT repressor bound to an acyl-Acyl carrier protein. Although FabT defects confer reduced virulence in animal models, spontaneous f
Externí odkaz:
https://doaj.org/article/7f491b6bc68941ea8141f6da9848c69d
Publikováno v:
Cancer Research. 83:P4-03
Background Historically, standard-of-care treatments for human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (mBC) have been pertuzumab and trastuzumab combined with a chemotherapeutic agent in first line (1L), and tras
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7b4f64001a2cf4afec64cdd0ab08127
https://doi.org/10.1158/1538-7445.sabcs22-p4-03-34
https://doi.org/10.1158/1538-7445.sabcs22-p4-03-34
Autor:
Devon K Check, Bradford E. Jackson, Lisa Spees, Michaela Ann Dinan, Jackie Kwong, Sandhya Mehta, Stephanie B. Wheeler, Lauren E. Wilson, Eleanor Faherty, Katherine Elizabeth Reeder-Hayes, Clara Lam
Publikováno v:
Journal of Clinical Oncology. 40:399-399
399 Background: Metastatic breast cancer (mBC) expresses varied levels of HER2 protein. While HER2+ mBC patients are treated with anti-HER2 therapies, those with lower levels of HER2 expression [HER2-low; immunohistochemistry (IHC) 1+, IHC 2+ with In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::396952c9ee9efd36f1e80c2ecae061e7
https://doi.org/10.1200/jco.2022.40.28_suppl.399
https://doi.org/10.1200/jco.2022.40.28_suppl.399
Autor:
Jonathan K. Kish, Sandhya Mehta, Jackie Kwong, Clara Lam, Angelica Falkenstein, Cherrishe Brown-Bickerstaff, Dong Xiao, Bruce A. Feinberg
Publikováno v:
Journal of Clinical Oncology. 40:1036-1036
1036 Background: Trastuzumab Deruxtecan (T-DXd) was associated with an increased risk of interstitial lung disease (ILD)/pneumonitis (P) in metastatic breast cancer (mBC) patients (pts) in clinical trials, leading to ILD/P monitoring and management g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9e58713fa5b199930d7c8e4a9dac5dc3
https://doi.org/10.1200/jco.2022.40.16_suppl.1036
https://doi.org/10.1200/jco.2022.40.16_suppl.1036
Autor:
Paprapach Wongdontree, Aaron Millan-Oropeza, Jennifer Upfold, Jean-Pierre Lavergne, David Halpern, Clara Lambert, Adeline Page, Gérald Kénanian, Christophe Grangeasse, Céline Henry, Agnès Fouet, Karine Gloux, Jamila Anba-Mondoloni, Alexandra Gruss
Publikováno v:
iScience, Vol 27, Iss 4, Pp 109505- (2024)
Summary: Antibiotics inhibiting the fatty acid synthesis pathway (FASII) of the major pathogen Staphylococcus aureus reach their enzyme targets, but bacteria continue growth by using environmental fatty acids (eFAs) to produce phospholipids. We asses
Externí odkaz:
https://doaj.org/article/f6bf5f3ca6be4f448560f85bfcc04fd3
Autor:
Rebecca, Ehrenkranz, Clara, Lam, Valentina I, Petkov, David, Dilts, Steven, Cheng, Amy, Solis, Serban, Negoita
Publikováno v:
Journal of registry management. 45(4)
In 2017, the Surveillance, Epidemiology, and End Results (SEER) program piloted a reactive quality audit plan (r-QAP) to analyze Collaborative Stage (CS) tumor size in breast and pancreatic cancer. Preevaluation objectives were to establish procedure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1724f4af995ff15234a7fd84fa1bd89a
https://pubmed.ncbi.nlm.nih.gov/31490911
https://pubmed.ncbi.nlm.nih.gov/31490911